Loading paragraph...
Loading image...
Loading paragraph...
Loading paragraph...
Loading ticker_table...
Loading paragraph...
Loading company_card...
Loading paragraph...
Loading paragraph...
Loading company_card...
Loading paragraph...
Loading company_card...
Loading paragraph...
Loading company_card...
Loading paragraph...
Loading company_card...
Loading paragraph...
Loading paragraph...
Loading paragraph...
Loading hub_pages...
Loading paragraph...
Loading paragraph...
Loading faq...

About the Author

Keith Speights
Keith Speights is a contributing Motley Fool healthcare analyst covering publicly traded companies across pharmaceuticals, biotechnology, medical devices, technology, and marijuana. Prior to The Motley Fool, Keith was CEO of Constant Care Technology, a healthcare technology company; vice president of American HealthTech, a healthcare software company; and a director of operations for Blue Cross Blue Shield of Mississippi, a health insurer. He holds a B.S. in Industrial Engineering from Mississippi State University.
Keith Speights has positions in Intuitive Surgical. The Motley Fool has positions in and recommends Abbott Laboratories, Align Technology, Cochlear, Edwards Lifesciences, GE HealthCare Technologies, Intuitive Surgical, Kenvue, and TransMedics Group. The Motley Fool recommends GE Aerospace and Johnson & Johnson and recommends the following options: long January 2026 $13 calls on Kenvue. The Motley Fool has a disclosure policy.